期刊
CURRENT OPINION IN GENETICS & DEVELOPMENT
卷 15, 期 1, 页码 27-33出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2004.12.008
关键词
-
In 2003, a p53-expressing adenovirus was approved as a cancer therapy drug in China. Consequently, there has been a surge in the need to understand the regulation of wild type p53 function in vivo. The majority of the progress made during the past two years has focused on the cellular factors and post-translational modifications that regulate the expression levels and activities of p53 in response to stress signals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据